Transfusion-related acute lung injury: a clinical review

Three decades ago, transfusion-related acute lung injury (TRALI) was considered a rare complication of transfusion medicine. Nowadays, the US Food and Drug Administration acknowledge the syndrome as the leading cause of transfusion-related mortality. Understanding of the pathogenesis of TRALI has re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The Lancet (British edition) Ročník 382; číslo 9896; s. 984 - 994
Hlavní autoři: Vlaar, Alexander PJ, Juffermans, Nicole P
Médium: Journal Article
Jazyk:angličtina
Vydáno: Kidlington Elsevier Ltd 14.09.2013
Elsevier
Elsevier Limited
Témata:
Acute Lung Injury - diagnosis
Acute Lung Injury - etiology
Antibody Formation - physiology
Biological and medical sciences
Blood platelets
Blood transfusions
Cytokines
Cytokines - metabolism
Food and Drug Administration
General aspects
Humans
Internal Medicine
Lungs
Medical sciences
medicine
Mortality
Neutrophil Activation - immunology
Neutrophil Activation - physiology
Neutrophils - immunology
Pathogenesis
Patients
physicians
Pulmonary Edema - etiology
Risk factors
Sepsis
Studies
Surgery
Time Factors
Transfusion
Transfusion Reaction
United States
Ventilators
United States
Medicine
Review
Transfusion related acute lung injury
Bibliographic review
ISSN:0140-6736, 1474-547X, 1474-547X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Three decades ago, transfusion-related acute lung injury (TRALI) was considered a rare complication of transfusion medicine. Nowadays, the US Food and Drug Administration acknowledge the syndrome as the leading cause of transfusion-related mortality. Understanding of the pathogenesis of TRALI has resulted in the design of preventive strategies from a blood-bank perspective. A major breakthrough in efforts to reduce the incidence of TRALI has been to exclude female donors of products with high plasma volume, resulting in a decrease of roughly two-thirds in incidence. However, this strategy has not completely eradicated the complication. In the past few years, research has identified patient-related risk factors for the onset of TRALI, which have empowered physicians to take an individualised approach to patients who need transfusion.
Bibliografie:http://dx.doi.org/10.1016/S0140-6736(12)62197-7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0140-6736
1474-547X
1474-547X
DOI:10.1016/S0140-6736(12)62197-7